⏰ Last chance! Join Premium for $20/month before it increases to $49/month.

Atea Pharmaceuticals, Inc. Common Stock

$5.31
-0.01 (-0.19%)

Market Capitalization:

$425.89M

Live Price

Live Volume

Chart Volume 0
Volume 0
5 sec

Atea Pharmaceuticals Market Segments

Overnight

*No Trades in Segment

After Hours

*No Trades in Segment

Regular Trading Hours

*No Trades in Segment

Premarket

*No Trades in Segment

After Hours Yesterday

+0.00(+0.00%)
Open$5.31
Close$5.31
Low$5.31
Low Change0.00 (0.00%)
High$5.31
High Change+0.00 (+0.00%)
Range$0.00
Volume68.839K
Dollar Volume$365.54K

Regular Trading Hours Yesterday

+0.09(+1.72%)
Open$5.23
Close$5.32
Low$5.18
Low Change-0.05 (-0.96%)
High$5.38
High Change+0.15 (+2.88%)
Range$0.20
Volume343.868K
Dollar Volume$1.83M

Premarket Yesterday

*No Trades in Segment

Atea Pharmaceuticals News

There is no current news for this stock at the moment.

Atea Pharmaceuticals Top Trades

We are still processing the top long and short trades for today. Please refresh the page in 10 minutes or sign up for Finsuba Premium for real time trade insights.

Atea Pharmaceuticals Moving Averages

5 Day Moving Average (SMA5)$5.46
10 Day Moving Average (SMA10)$5.50
20 Day Moving Average (SMA20)$5.45
50 Day Moving Average (SMA50)$5.08
100 Day Moving Average (SMA100)$4.92
200 Day Moving Average (SMA200)$4.66

Atea Pharmaceuticals Statistics

Average Volume (30 Days)262.94K
P/E Ratio (Current)-2.51
EPS (Current)-$2.06
Dividend Yield0.00%
Free Cash Flow-$152.07M
Cash Ratio2.72
Current Ratio8.13
Quick Ratio8.13
Debt to Equity0.00
Enterprise Value$338.91M
EV to EBITDA-1.85
EV to Sales
Price to Book2.03
Price to Cash Flow
Price to Free Cash Flow
Price to Sales
Return on Assets-0.71%
Return on Equity-0.81%

Atea Pharmaceuticals Stock Splits

There has been 1 stock split for Atea Pharmaceuticals (AVIR). The reverse stock split occured on February 14, 2018 and reduced the outstanding shares at a ratio of 11:1.

DateTypeRatio
Feb 14, 2018Reverse11:1

Atea Pharmaceuticals Dividends

There have been no dividends for Atea Pharmaceuticals (AVIR).